This is transformational for most organisations. Risk, due diligence and approvals would take at minimum 6 months, even longer for the Government. But once confidence has been instilled in early adopters, uptake across industries will be much easier.
Agreed we're not going to see massive leaps before the end of the calendar year, but once we seal the deal with some of the noted opportunities, the growth can be expediential. Likely there will be a CR in the future, question of if we can get some momentum before we get there
- Forums
- ASX - By Stock
- AL3
- Ann: Investor Presentation
AL3
aml3d limited
Add to My Watchlist
14.3%
!
24.0¢

Ann: Investor Presentation, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
0.030(14.3%) |
Mkt cap ! $129.0M |
Open | High | Low | Value | Volume |
21.5¢ | 24.0¢ | 21.0¢ | $1.410M | 6.096M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 133461 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 0.235 |
6 | 494544 | 0.230 |
6 | 235043 | 0.225 |
4 | 187954 | 0.220 |
2 | 54650 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 133461 | 4 |
0.245 | 432327 | 9 |
0.250 | 161504 | 12 |
0.255 | 363716 | 5 |
0.260 | 187337 | 4 |
Last trade - 16.20pm 04/07/2025 (20 minute delay) ? |
Featured News
AL3 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online